[1] Jemal, A., Siegel, R., Ward, E., Hao, Y.P., Xu J.Q., Murray, T. and Thun, M.J. (2008) Cancer statistics, 2008. CA: A Cancer Journal for Clinicians, 58, 71-96.
http://dx.doi.org/10.3322/CA.2007.0010
[2] Jemal, A., Center, M.M., Ward, E. and Thun, M.J. (2009) Cancer occurrence. Methods in Molecular Biology, 471, 3-29. http://dx.doi.org/10.1007/978-1-59745-416-2_1
[3] Parkin, D.M., Bray, F., Ferlay, J. and Pisani, P. (2005) Global cancer statistics, 2002. CA: A Cancer Journal for Clinicians, 55, 74-108.
http://dx.doi.org/10.3322/canjclin.55.2.74
[4] Dobrossy, L. (2005) Epidemiology of head and neck cancer: Magnitude of the problem. Cancer and Metastasis Reviews, 24, 9-17.
http://dx.doi.org/10.1007/s10555-005-5044-4
[5] Ramqvist, T. and Dalianis, T. (2010) Oropharyngeal cancer epidemic and human papillomavirus. Emerging Infectious Diseases, 16, 1671-1677.
http://dx.doi.org/10.3201/eid1611.100452
[6] Medzhitov, R., Preston-Hurlburt, P. and Janeway, Jr. C.A. (1997) A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature, 388, 394-397.
http://dx.doi.org/10.1038/41131
[7] Takeda, K., Kaisho, T. and Akira, S. (2003) Toll-like receptors. Annual Review of Immunology, 21, 335-376.
http://dx.doi.org/10.1146/annurev.immunol.21.120601.141126
[8] Akira, S., Uematsu, S. and Takeuchi, O. (2006) Pathogen recognition and innate immunity. Cell, 124, 783-801.
http://dx.doi.org/10.1016/j.cell.2006.02.015
[9] Furrie, E., et al. (2005) Toll-like receptors-2, -3 and -4 expression patterns on human colon and their regulation by mucosal-associated bacteria. Immunology, 115, 565-574.
http://dx.doi.org/10.1111/j.1365-2567.2005.02200.x
[10] Kelly, M.G., et al. (2006) TLR-4 signaling promotes tumor growth and paclitaxel chemoresistance in ovarian cancer. Cancer Research, 66, 3859-3868.
http://dx.doi.org/10.1158/0008-5472.CAN-05-3948
[11] Lee, J.W., et al. (2007) Increased toll-like receptor 9 expression in cervical neoplasia. Molecular Carcinogenesis, 46, 941-947. http://dx.doi.org/10.1002/mc.20325
[12] Park, J.H., et al. (2011) Toll-like receptor 5 activation promotes migration and invasion of salivary gland adenocarcinoma. Journal of Oral Pathology & Medicine, 40, 187-193.
http://dx.doi.org/10.1111/j.1600-0714.2010.00929.x
[13] He, W., et al. (2007) TLR4 signaling promotes immune escape of human lung cancer cells by inducing immunosuppressive cytokines and apoptosis resistance. Molecular Immunology, 44, 2850-2859.
http://dx.doi.org/10.1016/j.molimm.2007.01.022
[14] Droemann, D., et al. (2005) Human lung cancer cells express functionally active Toll-like receptor 9. Respiratory Research, 6, 1. http://dx.doi.org/10.1186/1465-9921-6-1
[15] Koch, A.E., et al. (1992) Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science, 258, 1798-801. http://dx.doi.org/10.1126/science.1281554
[16] Strieter, R.M., et al. (1995) Role of C-X-C chemokines as regulators of angiogenesis in lung cancer. Journal of Leukocyte Biology, 57, 752-762.
[17] Murdoch, C., et al. (1999) Cxc chemokine receptor expression on human endothelial cells. Cytokine, 11, 704-712. http://dx.doi.org/10.1006/cyto.1998.0465
[18] Dil, N. and Banerjee, A.G. (2011) A role for aberrantly expressed nuclear localized decorin in migration and invasion of dysplastic and malignant oral epithelial cells. Head & Neck Oncology, 3, 44.
http://dx.doi.org/10.1186/1758-3284-3-44
[19] Lalla, R.V., et al. (2001) Fibrin induces IL-8 expression from human oral squamous cell carcinoma cells. Oral Oncology, 37, 234-242.
http://dx.doi.org/10.1016/S1368-8375(00)00090-7
[20] Dil, N.and Banerjee, A.G. (2012) Knockdown of aberrantly expressed nuclear localized decorin attenuates tumour angiogenesis related mediators in oral cancer progression model in vitro. Head & Neck Oncology, 4, 11.
http://dx.doi.org/10.1186/1758-3284-4-11
[21] Banerjee, A.G., et al. (2003) Aberrant expression and localization of decorin in human oral dysplasia and squamous cell carcinoma. Cancer Research, 63, 7769-7776.
[22] Hu, L., et al. (1991) Abnormal expression of retinoic acid receptors and keratin 19 by human oral and epidermal squamous cell carcinoma cell lines. Cancer Research, 51, 3972-3981.
[23] Hsu, S. et al. (2002) Transforming growth factor beta 1 dysregulation in a human oral carcinoma tumour progression model. Cell Proliferation, 35, 183-192.
http://dx.doi.org/10.1046/j.1365-2184.2002.00237.x
[24] Yu, L. and Chen, S. (2008) Toll-like receptors expressed in tumor cells: Targets for therapy. Cancer Immunology, Immunotherapy, 57, 1271-1278.
http://dx.doi.org/10.1007/s00262-008-0459-8
[25] Neill, T., et al. (2012) Decorin: A guardian from the matrix. American Journal of Pathology, 181, 380-387.
http://dx.doi.org/10.1016/j.ajpath.2012.04.029
[26] Zafiropoulos, A., et al. (2008) Decorin-induced growth inhibition is overcome through protracted expression and activation of epidermal growth factor receptors in osteosarcoma cells. Molecular Cancer Research, 6, 785-794. http://dx.doi.org/10.1158/1541-7786.MCR-07-0165
[27] Zafiropoulos, A. and Tzanakakis, G.N. (2008) Decorin-mediated effects in cancer cell biology. Connective Tissue Research, 49, 244-248.
http://dx.doi.org/10.1080/03008200802147746
[28] Santra, M., et al. (2008) Ectopic decorin expression up-regulates VEGF expression in mouse cerebral endothelial cells via activation of the transcription factors Sp1, HIF1alpha, and Stat 3. Journal of Neurochemistry, 105, 324-337.
http://dx.doi.org/10.1111/j.1471-4159.2007.05134.x
[29] Schmausser, B., et al. (2005) Toll-like receptors TLR4, TLR5 and TLR9 on gastric carcinoma cells: An implication for interaction with Helicobacter pylori. International Journal of Medical Microbiology, 295, 179-185.
http://dx.doi.org/10.1016/j.ijmm.2005.02.009
[30] Pimentel-Nunes, P., et al. (2011) Increased expression of Toll-like receptors (TLR) 2, 4 and 5 in gastric dysplasia. Pathology & Oncology Research, 17, 677-683.
http://dx.doi.org/10.1007/s12253-011-9368-9
[31] Kim, W.Y., et al. (2008) Increased expression of Tolllike receptor 5 during progression of cervical neoplasia. International Journal of Gynecological Cancer, 18, 300-305.
http://dx.doi.org/10.1111/j.1525-1438.2007.01008.x
[32] Song, E.J., et al. (2011) Flagellin promotes the proliferation of gastric cancer cells via the Toll-like receptor 5. International Journal of Medical Microbiology, 28, 115-119.
[33] Kauppila, J.H., et al. (2013) Toll-like receptor 5 (TLR5) expression is a novel predictive marker for recurrence and survival in squamous cell carcinoma of the tongue. British Journal of Cancer, 108, 638-643.
http://dx.doi.org/10.1038/bjc.2012.589
[34] Schaefer, L., et al. (2005) The matrix component biglycan is proinflammatory and signals through Toll-like receptors 4 and 2 in macrophages. Journal of Clinical Investigation, 115, 2223-2233.
http://dx.doi.org/10.1172/JCI23755
[35] Frey, H., et al. (2013) Biological interplay between proteoglycans and their innate immune receptors in inflammation. FEBS Journal, 280, 2165-2179.
[36] Chen, G.Y. and Nunez, G. (2010) Sterile inflammation: Sensing and reacting to damage. Nature Reviews Immunology, 10, 826-837. http://dx.doi.org/10.1038/nri2873